Abstract: Disclosed are systems and methods for ink management utilizing a master controller, which receives configuration information from one or more ink pens, reservoirs, printheads, or ink level measurement devices. The controller receives master controller commands; reads data from system sensors; reads and writes data to and from smart chips associated with elements in the system and a non-volatile memory associated with an ink management controller; and independently takes action in response to data from a smart chip or sensor.

Abstract: A pharmaceutical composition for prevention and treatment of cancer, cardiovascular disease and antioxidation contains resveratol. The new method of process for producing resveratol is extracted resveratol from oil residue and stems of peanuts or stems of other cheap herbs. Derivates of resveratol include procyanidins, polydatin, peceid, anthraglycoside, emodin, chrysophanol and quercetin.

Abstract: The new pharmaceutics preparation of HHT derivates and HHT-derivates containing sterically stabilized liposomes (HHT-SSL) in accordance with the present invention are for inducing differentiation cancer cells to resemble normal cells and apoptosis of cancer cells. Anticancer molecular mechanism of HHT-SSL and HHT includes inhibiting oncogenes, increasing activity of tumor suppressor, inhibiting cancer cells proliferation, inhibiting DNA methylation, and increasing activity of APO-2L.

Abstract: Three new safe pharmaceutical compositions in accordance with the present invention are for treatment and prevention of malignant pleural effusion and increase immune function comprise Lan Xiang Xi (LX) and polysaccharide of Dang Gui.

Abstract: The present invention related to safe botanical drug for treatment and prevention of Alzheimer's disease. Specifically, this invention proves a safe botanical drug, Huperzine (HUE) and Clausenamide (CLE) and their preparation. HUE has the following pharmaceutical functions: inhibiting acetylcholinesterase (CAT), increasing memory, decreasing Alzheimer amyloid protein, increasing RNA and protein synthesis of brain, increasing calcium in brain, decreasing superoxide anion. CLE has the following pharmaceutical functions: increasing memory, decreasing Alzheimer amyloid protein, increasing RNA and protein synthesis of brain, increasing calcium in brain, decreasing superoxide anion, increasing long-term potentiation and increasing dopanmine (DA). It is important that HUE combined with CLE have stronger function as mentioned above.

Abstract: This invention relates to new safe botanical drug, which is used for increasing immune function and decreasing side effects of chemotherapy.

Abstract: This invention relates to new safe botanical drug, which is used for treatment and prevention of influenza and increasing immune function. Specifically, this invention provides a method for producing pure Banlangensu (PBLG), BLG's Polysaccharide and Isatin B.

Abstract: A pharmaceutical composition for treatment of cardiovascular disease, increasing immune function and decreasing serum lipids contains soybean saponins. The process for producing soybean saponins from soybean residue and related pharmacological effects are provided.

Abstract: The safe pharmaceutical composition and processed are provided for treating and preventing alcohol abuse and increasing immune function. The pharmaceutical composition is composed of Puerarin derivatives, which includes Puerarin, Daidzein or Genistia.

Abstract: The new pharmaceutical compositions and processes are provided for reducing both hyperlipidemia and platelet-aggregation (PHP).The fine-PHP is composed of following ingredients: Scoparone or Aurapten, Curcumin, Ferulic Acid, Yejuhua-flavonoid and additive ingredient--fish oil. The compositions are nontoxic.

Abstract: A new pharmaceutical composition and processes are provided for treating and preventing diabetes.The pharmaceutical composition is composed of three ingredients: Oleanolic acid, Saponins of Litchi and Kuguasu.The pharmaceutical composition is nontoxic.

Abstract: A new pharmaceutical composition and processes are provided for treating and preventing diabetes.The pharmaceutical composition is composed of three ingredients: Oleanolic acid, Saponins of Litchi and Kuguasu.The pharmaceutical composition is nontoxic.

Abstract: The new safe pharmaceutical composition (SDI II) and processes are provided for decreasing side effects of antiviral drugs and increasing the immune function.The pharmaceutical composition is composed of two ingredients: Polysaccharides of Wang Qi and Ginsenoside. The SDI II is nontoxic.

Abstract: The new pharmaceutical composition (PTC) and process are provided for treating and preventing cardiovascular disease.The fine-PTC is composed of following ingredients: Puerarin or derivative of Puerarin; Danshensu or Danshenketone; Tetramethyl pyrazine; Polysacccharides and Saponin of Dangshen.The composition is nontoxic.

Abstract: The new pharamaceutical composition (PTC) and process are provided for treating and preventing cardiovascular disease.The fine-PTC is composed of following ingredients: Puerarin or derivate of Puerarin; Danshensu or Danshenketone; Tetramethyl pyrazine; Polysaccharides and Ssponin of Dangshen.The composition is nontoxic.

Abstract: The new pharmaceutical composition (PTC) and process are provided for treating and preventing cardiovascular disease.The fine-PTC is composed of following ingredients: Puerarin or derivate of Puerarin; Danshensu or Danshenketone; Tetramethyl pyrazine; Polysaccharides and Saponin of Dangshen.The composition is nontoxic.

Abstract: The new pharmaceutical composition and processes are provided for treating and preventing diabetes.The pharmaceutical composition is composed of three ingredients: Oleanolic acid, Saponins of Litchi and Kuguasu.The pharmaceutical composition is nontoxic.

Abstract: A safe pharmaceutical composition for treatment and prevention of infections caused by viruses and increasing immune function. The pharmaceutical composition is composed of four active ingredients: Polysaccharides of Wang Qi, Banlankensu, Yejuhua-flavonoid and Guanzhongsu and method of making the same.

Abstract: The new pharmaceutical composition (PTC) and process are provided for treating and preventing cardiovascular disease.The fine-PTC is composed of following ingredients: Puerarin or derivate of Puerarin; Danshensu or Danshenketone; Tetramethyl pyrazine; Polysaccharides and Saponin of Dangshen.The composition is nontoxic.

Abstract: A safe pharmaceutical composition for treatment and prevention of infections caused by viruses and increasing immune function. The pharmaceutical composition is composed of four active ingredients: Polysaccharides of Wang Qi, Banlankensu, Yejuhua-flavonoid and Guanzhongsu and method of making the same.